Dianthus Therapeutics | Passività Correnti



Current Liabilities Cambiamento Data
Adcock Ingram Holdings ZAR 2.53B 85.57M 2024-06
Alaunos Therapeutics USD 4K 822K 2024-10
Avita Medical AUD 20.16M 6.37M 2024-12
Celltrion KRW 3.03T 141.48B 2024-09
Cspc Pharmaceutical CNY 10.44B 252.73M 2024-06
Dianthus Therapeutics USD 15.71M 5.68M 2024-09
Ecofibre AUD 20.78M 803K 2024-06
IQVIA Holdings USD 6.96B 35M 2024-12
Kangmei Pharma CNY 4.91B 208.41M 2024-09
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Laboratorios Farma EUR 272.46M 81.21M 2024-06
Malin Corporation EUR 500K 500K 2024-06
Medical Developments International AUD 9.55M 1.61M 2024-06
Moderna USD 2.21B 5M 2024-12
Neuren Pharmaceuticals AUD 45.76M 36.79M 2024-12
Organigram Holdings CAD 68.96M 15.64M 2024-12
Organon & Co USD 2.79B 35M 2024-09
Pharma Mar EUR 82.69M 6.75M 2024-12
Qiagen NV USD 543.63M 584.94M 2024-12
Revvity USD 653.1M 34.84M 2024-12
Sartorius EUR 977M 116.3M 2024-09
Sino Biopharmaceutical CNY 21.95B 657.56M 2024-06
Tectonic Therapeutic USD 17.32M 8.68M 2024-09
Tilray USD 278.52M 15.02M 2024-11
Viatris USD 5.78B 1.73B 2024-12
Xeris Pharmaceuticals USD 100.44M 9.43M 2024-12
Zz Pientze Pharmaceu 3.1B 569.38M 2024-09



Dianthus Therapeutics Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.